Irinotecan plus temozolomide in relapsed Ewing sarcoma: An integrated analysis of retrospective studies

The prognosis of patients with relapsed Ewing sarcoma is poor. In this study, we aimed to pooledanalyze the efficacy and safety of the combination of irinotecan and temozolomide in treating patients with relapsed Ewing sarcoma.